ABSTRACT
BACKGROUND: The 30â³ sit to stand test is a submaximal exercise test that assesses functional capacity and it has been validated for various pathologies. Although it has been used in individuals with obesity, its reproducibility in this population has not yet been determined. The main objective of this study was to determine the reproducibility and safety of the 30â³ sit to stand test in individuals with overweight or obesity and with cardiovascular risk factors. METHODS: A cross-sectional study was performed. Individuals with obesity or overweight who also presented cardiovascular risk factors were evaluated with the 30â³ sit to stand test. The reproducibility and safety of the 30" sit to stand test were determined, as well as its association with other functional tests and anthropometric characteristics. RESULTS: 59 individuals (27 men, 32 women) with obesity or overweight and cardiovascular risk factors, aged 57.93 (9.62) years, were included in the study. The 30â³ sit to stand test showed good overall reproducibility (0.907 ICC) and significant correlation with the 6-minute walk test, handgrip strength test, body fat percentage and waist - height index, with a similar hemodynamic response to the 6-minute walk test. CONCLUSION: The 30" sit to stand test is a highly reproducible and safe test for individuals with obesity and cardiovascular risk factors, with a significant correlation to anthropometric characteristics and other functional tests regularly used for the evaluation of individuals with obesity.
Subject(s)
Cardiovascular Diseases , Overweight , Male , Humans , Female , Overweight/complications , Hand Strength , Cross-Sectional Studies , Reproducibility of Results , Cardiovascular Diseases/etiology , Risk Factors , Obesity/complications , Heart Disease Risk FactorsABSTRACT
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.The purpose of this update was to determine differences in patient-reported chronic toxicity and disease outcomes with intensity-modulated radiation therapy (IMRT) compared with conventional pelvic radiation. Patients with cervical and endometrial cancers who received postoperative pelvic radiation were randomly assigned to conventional radiation therapy (CRT) or IMRT. Toxicity and quality of life were assessed using Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events, Expanded Prostate Cancer Index Composite (EPIC) bowel and urinary domains, and Functional Assessment of Cancer Therapy-General. Between 2012 and 2015, 279 eligible patients were enrolled to the study with a median follow-up of 37.8 months. There were no differences in overall survival (P = .53), disease-free survival (P = .21), or locoregional failure (P = .81). One year after RT, patients in the CRT arm experienced more high-level diarrhea frequency (5.8% IMRT v 15.1% CRT, P = .042) and a greater number had to take antidiarrheal medication two or more times a day (1.2% IMRT v 8.6% CRT, P = .036). At 3 years, women in the CRT arm reported a decline in urinary function, whereas the IMRT arm continued to improve (mean change in EPIC urinary score = 0.5, standard deviation = 13.0, IMRT v -6.0, standard deviation = 14.3, CRT, P = .005). In conclusion, IMRT reduces patient-reported chronic GI and urinary toxicity with no difference in treatment efficacy at 3 years.
Subject(s)
Radiation Injuries , Radiotherapy, Conformal , Radiotherapy, Intensity-Modulated , Antidiarrheals , Female , Humans , Male , Patient Reported Outcome Measures , Quality of Life , Radiation Injuries/epidemiology , Radiation Injuries/etiology , Radiation Injuries/prevention & control , Radiotherapy, Conformal/adverse effects , Radiotherapy, Intensity-Modulated/adverse effects , Radiotherapy, Intensity-Modulated/methodsABSTRACT
We are reporting 16 pediatric patients (ages 0-18-years-old) who presented to our urban hospital emergency room with seizures and coronavirus disease 2019 (COVID-19) during the surge of the Omicron variant. There was an increased number of pediatric patients with seizures and COVID-19 during this period as compared to prior COVID-19 surges. The 16 patients ranged in age from 3 months to 12 years of age. Five of the 16 patients (31%) had a prior history of epilepsy. Eight patients (50%) presented in status epilepticus, and in six patients (38%) the seizures appeared to have focal features. Fourteen patients (88%) presented with a complex provoked seizure defined as exhibiting either focality, seizure >5 min in length, or more than one seizure in 24 h. We suggest that in the pediatric population, when compared to prior variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Omicron variant is more likely to be associated with neurologic symptoms, including complex provoked seizures.
Subject(s)
COVID-19 , Status Epilepticus , Adolescent , COVID-19/complications , Child , Child, Preschool , Humans , Infant , Infant, Newborn , SARS-CoV-2 , Seizures/diagnosis , Seizures/epidemiology , Seizures/etiology , Status Epilepticus/diagnosis , Status Epilepticus/epidemiology , Status Epilepticus/etiologyABSTRACT
OBJECTIVE: To determine whether there is a disparity in access to telemedical care that may be a function of socioeconomic status, language, or other demographic factors during the peak of the coronavirus disease 2019 (COVID-19) pandemic at a highly affected urban center (Montefiore Medical Center) in Bronx, NY. METHODS: We retrospectively investigated potential patient characteristics that might be associated with an increased likelihood of receiving a telephone visit as opposed to a televideo visit for patients followed in the pediatric neurology, adult epilepsy, and general neurology practices at Montefiore Medical Center during the 30-day period starting April 2, 2020, at the peak of the COVID-19 pandemic in New York. RESULTS: We found that patients who had telephone encounters, as opposed to televideo encounters, were overall older, less likely to have commercial insurance, and more likely to have Medicaid. Among pediatric patients, a preferred language other than English was also associated with a higher proportion of telephone encounters. New patients in both the adult and pediatric groups were more likely to have televideo visits. CONCLUSIONS: Our findings identify demographic factors, including age, insurance type, and language preference, which may play a role in access to televideo encounters among neurology patients in an urban center during the COVID-19 pandemic. We suggest several potential practice, institution, and community-based interventions, which might further expand access to televideo care for neurology patients.
ABSTRACT
OBJECTIVE: Acute encephalopathy may occur in COVID-19-infected patients. We investigated whether medically indicated EEGs performed in acutely ill patients under investigation (PUIs) for COVID-19 report epileptiform abnormalities and whether these are more prevalent in COVID-19 positive than negative patients. METHODS: In this retrospective case series, adult COVID-19 inpatient PUIs underwent EEGs for acute encephalopathy and/or seizure-like events. PUIs had 8-channel headband EEGs (Ceribell; 20 COVID-19 positive, 6 COVID-19 negative); 2 more COVID-19 patients had routine EEGs. Overall, 26 Ceribell EEGs, 4 routine and 7 continuous EEG studies were reviewed. EEGs were interpreted by board-certified clinical neurophysiologists (n = 16). EEG findings were correlated with demographic data, clinical presentation and history, and medication usage. Fisher's exact test was used. RESULTS: We included 28 COVID-19 PUIs (30-83 years old), of whom 22 tested positive (63.6% males) and 6 tested negative (33.3% male). The most common indications for EEG, among COVID-19-positive vs COVID-19-negative patients, respectively, were new onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%), even among patients without prior history of seizures (11/17, 64.7%; 2/6, 33.3%). Sporadic epileptiform discharges (EDs) were present in 40.9% of COVID-19-positive and 16.7% of COVID-19-negative patients; frontal sharp waves were reported in 8/9 (88.9%) of COVID-19-positive patients with EDs and in 1/1 of COVID-19-negative patient with EDs. No electrographic seizures were captured, but 19/22 COVID-19-positive and 6/6 COVID-19-negative patients were given antiseizure medications and/or sedatives before the EEG. SIGNIFICANCE: This is the first preliminary report of EDs in the EEG of acutely ill COVID-19-positive patients with encephalopathy or suspected clinical seizures. EDs are relatively common in this cohort and typically appear as frontal sharp waves. Further studies are needed to confirm these findings and evaluate the potential direct or indirect effects of COVID-19 on activating epileptic activity.
ABSTRACT
INTRODUCTION: To describe patient-reported outcomes and toxicities at time of treatment discontinuation secondary to progression or toxicities in advanced/recurrent cervical cancer patients receiving chemotherapy with bevacizumab. METHODS: Summarize toxicity, grade, and health-related quality of life within 1 month of treatment discontinuation for women receiving chemotherapy with bevacizumab in GOG240. RESULTS: Of the 227 patients who received chemotherapy with bevacizumab, 148 discontinued study protocol treatment (90 for disease progression and 58 for toxicity). The median survival time from treatment discontinuation to death was 7.9 months (95% CI 5.0 to 9.0) for those who progressed versus 12.1 months (95% CI 8.9 to 23.2) for those who discontinued therapy due to toxicities. The most common grade 3 or higher toxicities included hematologic, gastrointestinal, and pain. Some 57% (84/148) of patients completed quality of life assessment within 1 month of treatment discontinuation. Those patients who discontinued treatment due to progression had a mean decline in the FACT-Cx TOI of 3.2 points versus 2.2 in patients who discontinued therapy due to toxicity. This was a 9.9 point greater decline in the FACT-Cx TOI scores than those who discontinued treatment due to progression (95% CI 2.8 to 17.0, p=0.007). The decline in quality of life was due to worsening physical and functional well-being. Those who discontinued treatment due to toxicities had worse neurotoxicity and pain. DISCUSSION: Patients who discontinued chemotherapy with bevacizumab for toxicity experienced longer post-protocol survival but significantly greater declination in quality of life than those with progression. Future trial design should include supportive care interventions that optimize physiologic function and performance status for salvage therapies.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Uterine Cervical Neoplasms/drug therapy , Withholding Treatment , Adult , Aged , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Cisplatin/administration & dosage , Cisplatin/adverse effects , Female , Humans , Middle Aged , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Patient Reported Outcome Measures , Quality of Life , Topotecan/administration & dosage , Topotecan/adverse effectsSubject(s)
Acquired Immunodeficiency Syndrome/physiopathology , HIV Infections/physiopathology , HIV , Muscle Strength Dynamometer/statistics & numerical data , Physical Functional Performance , Acquired Immunodeficiency Syndrome/virology , Adult , Anthropometry , Biomarkers/analysis , Body Mass Index , Cross-Sectional Studies , Disease Progression , Elbow/physiopathology , Elbow/virology , Female , HIV Infections/virology , Humans , Knee/physiopathology , Knee/virology , Male , Muscle Strength , Reference Values , Walk TestABSTRACT
PURPOSE: In oncology trials, the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) is the standard tool for reporting adverse events (AEs), but it may underreport symptoms experienced by patients. This analysis of the NRG Oncology RTOG 1203 compared symptom reporting by patients and clinicians during radiotherapy (RT). PATIENTS AND METHODS: Patients with cervical or endometrial cancer requiring postoperative RT were randomly assigned to standard 4-field RT or intensity-modulated RT (IMRT). Patients completed the 6-item patient-reported outcomes version of the CTCAE (PRO-CTCAE) for GI toxicity assessing abdominal pain, diarrhea, and fecal incontinence at various time points. Patients reported symptoms on a 5-point scale. Clinicians recorded these AEs as CTCAE grades 1 to 5. Clinician- and patient-reported AEs were compared using McNemar's test for rates > 0%. RESULTS: Of 278 eligible patients, 234 consented and completed the PRO-CTCAE. Patients reported high-grade abdominal pain 19.1% (P < .0001), high-grade diarrhea 38.5% (P < .0001), and fecal incontinence 6.8% more frequently than clinicians. Similar effects were seen between grade ≥ 1 CTCAE toxicity and any-grade patient-reported toxicity. Between-arm comparison of patient-reported high-grade AEs revealed that at 5 weeks of RT, patients who received IMRT experienced fewer GI AEs than patients who received 4-field pelvic RT with regard to frequency of diarrhea (18.2% difference; P = .01), frequency of fecal incontinence (8.2% difference; P = .01), and interference of fecal incontinence (8.5% difference; P = .04). CONCLUSION: Patient-reported AEs showed a reduction in symptoms with IMRT compared with standard RT, whereas clinician-reported AEs revealed no difference. Clinicians also underreported symptomatic GI AEs compared with patients. This suggests that patient-reported symptomatic AEs are important to assess in this disease setting.
Subject(s)
Patient Reported Outcome Measures , Radiotherapy, Intensity-Modulated/methods , Female , Humans , MaleABSTRACT
OBJECTIVE: Women with endometrial or cervical cancer at risk for recurrence receive postoperative radiation therapy (RT). A patient reported outcomes (PRO) instrument to assess bowel and urinary toxicities is the Expanded Prostate Cancer Index Composite (EPIC), which has been validated in men with prostate cancer. As this instrument specifically measures bowel toxicity and the degree to which this is a problem, it was used in NRG Oncology/RTOG 1203 to compare intensity modulated RT (IMRT) to standard RT. This paper reports on the expanded validation of EPIC for use in women receiving pelvic RT. METHODS: In addition to the EPIC bowel domain, urinary toxicity (EPIC urinary domain), patient reported bowel toxicities (PRO-CTCAE) and quality of life (Functional Assessment of Cancer Therapy (FACT)) were completed before, during and after treatment. Sensitivity, reliability and concurrent validity were assessed. RESULTS: Mean bowel and urinary scores among 278 women enrolled were significantly worse during treatment and differed between groups. Acceptable to good reliability for bowel and urinary domain scores were obtained at all time points with the exception of one at baseline. Correlations between function and bother scores within the bowel and urinary domains were consistently stronger than those across domains. Correlations between bowel domain scores and PRO-CTCAE during treatment were stronger than those with the FACT. CONCLUSION: Correlations within and among the instruments indicate EPIC bowel and urinary domains are measuring conceptually discrete components of health. These EPIC domains are valid, reliable and sensitive instruments to measure PRO among women undergoing pelvic radiation.
Subject(s)
Endometrial Neoplasms/radiotherapy , Intestinal Diseases/etiology , Urologic Diseases/etiology , Uterine Cervical Neoplasms/radiotherapy , Adult , Aged , Aged, 80 and over , Endometrial Neoplasms/surgery , Female , Humans , Hysterectomy , Intestinal Diseases/diagnosis , Intestines/radiation effects , Middle Aged , Patient Reported Outcome Measures , Postoperative Care , Quality of Life , Radiation Injuries/diagnosis , Radiotherapy, Intensity-Modulated , Reproducibility of Results , Urethra/radiation effects , Urologic Diseases/diagnosis , Uterine Cervical Neoplasms/surgeryABSTRACT
Purpose NRG Oncology/RTOG 1203 was designed to compare patient-reported acute toxicity and health-related quality of life during treatment with standard pelvic radiation or intensity-modulated radiation therapy (IMRT) in women with cervical and endometrial cancer. Methods Patients were randomly assigned to standard four-field radiation therapy (RT) or IMRT radiation treatment. The primary end point was change in patient-reported acute GI toxicity from baseline to the end of RT, measured with the bowel domain of the Expanded Prostate Cancer Index Composite (EPIC). Secondary end points included change in patient-reported urinary toxicity, change in GI toxicity measured with the Patient-Reported Outcome Common Terminology Criteria for Adverse Events, and quality of life measured with the Trial Outcome Index. Results From 2012 to 2015, 289 patients were enrolled, of whom 278 were eligible. Between baseline and end of RT, the mean EPIC bowel score declined 23.6 points in the standard RT group and 18.6 points in the IMRT group ( P = .048), the mean EPIC urinary score declined 10.4 points in the standard RT group and 5.6 points in the IMRT group ( P = .03), and the mean Trial Outcome Index score declined 12.8 points in the standard RT group and 8.8 points in the IMRT group ( P = .06). At the end of RT, 51.9% of women who received standard RT and 33.7% who received IMRT reported frequent or almost constant diarrhea ( P = .01), and more patients who received standard RT were taking antidiarrheal medications four or more times daily (20.4% v 7.8%; P = .04). Conclusion Pelvic IMRT was associated with significantly less GI and urinary toxicity than standard RT from the patient's perspective.
Subject(s)
Endometrial Neoplasms/radiotherapy , Radiation Injuries/epidemiology , Radiotherapy/adverse effects , Radiotherapy/methods , Uterine Cervical Neoplasms/radiotherapy , Female , Humans , Patient Reported Outcome Measures , Pelvis/radiation effects , Radiation Injuries/etiology , Radiotherapy, Intensity-Modulated/adverse effectsABSTRACT
Ketogenic dietary therapies (KDTs) are established, effective nonpharmacologic treatments for intractable childhood epilepsy. For many years KDTs were implemented differently throughout the world due to lack of consistent protocols. In 2009, an expert consensus guideline for the management of children on KDT was published, focusing on topics of patient selection, pre-KDT counseling and evaluation, diet choice and attributes, implementation, supplementation, follow-up, side events, and KDT discontinuation. It has been helpful in outlining a state-of-the-art protocol, standardizing KDT for multicenter clinical trials, and identifying areas of controversy and uncertainty for future research. Now one decade later, the organizers and authors of this guideline present a revised version with additional authors, in order to include recent research, especially regarding other dietary treatments, clarifying indications for use, side effects during initiation and ongoing use, value of supplements, and methods of KDT discontinuation. In addition, authors completed a survey of their institution's practices, which was compared to responses from the original consensus survey, to show trends in management over the last 10 years.
ABSTRACT
OBJECTIVE: To describe and assess the effectiveness of a formal scholarly activity program for a highly integrated adult and pediatric neurology residency program. METHODS: Starting in 2011, all graduating residents were required to complete at least one form of scholarly activity broadly defined to include peer-reviewed publications or presentations at scientific meetings of formally mentored projects. The scholarly activity program was administered by the associate residency training director and included an expanded journal club, guided mentorship, a required grand rounds platform presentation, and annual awards for the most scholarly and seminal research findings. We compared scholarly output and mentorship for residents graduating within a 5-year period following program initiation (2011-2015) and during the preceding 5-year preprogram baseline period (2005-2009). RESULTS: Participation in scholarship increased from the preprogram baseline (24 of 53 graduating residents, 45.3%) to the postprogram period (47 of 57 graduating residents, 82.1%, p < 0.0001). Total scholarly output more than doubled from 49 activities preprogram (0.92/resident) to 139 postprogram (2.44/resident, p = 0.0002). The proportions of resident participation increased for case reports (20.8% vs 66.7%, p < 0.0001) and clinical research (17.0% vs 38.6%, p = 0.012), but were similar for laboratory research and topical reviews. The mean activities per resident increased for published abstracts (0.15 ± 0.41 to 1.26 ± 1.41, p < 0.0001), manuscripts (0.75 ± 1.37 to 1.00 ± 1.40, p = 0.36), and book chapters (0.02 ± 0.14 to 0.18 ± 0.60, p = 0.07). Rates of resident participation as first authors increased from 30.2% to 71.9% (p < 0.0001). The number of individual faculty mentors increased from 36 (preprogram) to 44 (postprogram). CONCLUSIONS: Our multifaceted program, designed to enhance resident and faculty engagement in scholarship, was associated with increased academic output and an expanded mentorship pool. The program was particularly effective at encouraging presentations at scientific meetings. Longitudinal analysis will determine whether such a program portfolio inspires an increase in academic careers involving neuroscience-oriented research.
Subject(s)
Biomedical Research , Education, Medical, Graduate , Internship and Residency/methods , Neurology/education , Pediatrics/education , Anniversaries and Special Events , Female , Humans , Longitudinal Studies , Male , Outcome Assessment, Health Care , Retrospective StudiesABSTRACT
This study examined outcomes and predictors of different types of responses to child pain used by caregivers of youth with chronic disease. Sixty-six children and adolescents (ages 7-18) with juvenile idiopathic arthritis answered questions about pain, pain interference in activities, and mood on a smartphone three times per day for one month, while a caregiver contemporaneously answered questions about their own mood and use of protecting, monitoring, minimizing, or distracting responses to their child's pain. Multilevel models were used to evaluate (a) how a child's pain and pain interference changes after a caregiver uses different types of pain responses; (b) the extent to which caregiver responses to pain vary across days; and (c) whether variability in caregiver responses to pain is predicted by changes in child pain characteristics, child mood, and/or caregiver mood. Results showed that children's pain intensity and pain interference increased following moments when caregivers used more protective responses, whereas children's pain interference decreased following times when caregivers responded with minimizing responses. Caregiver pain responses varied considerably across days, with caregivers responding with more protecting and monitoring responses and fewer minimizing responses at moments when their child reported high levels of pain unpleasantness and pain interference. Caregivers also were found to respond with fewer protective responses at moments when they themselves were in a more positive mood. Implications for clinical recommendations and future studies are discussed.
ABSTRACT
El objetivo de esta revisión fue establecer una asociación entre el nivel de actividad física realizada y la reducción del riesgo de muerte en pacientes hipertensos. Para la identificación de los documentos de esta revisión se realizó una búsqueda que abarcó estudios epidemiológicos tipo cohorte; las publicaciones relevantes fueron identificadas en las bases de datos biomédicas PubMed y Cochrane Collaboration, la estrategia de búsqueda siguió las recomendaciones de PRISMA. Los resultados mostraron que existe una asociación entre el nivel de actividad física y el riesgo de muerte en pacientes hipertensos. Se encontró una disminución del riesgo de muerte que oscila entre el 17-67% en los hipertensos que realizan altos niveles de actividad física. Los resultados apoyan la teoría de que la actividad física regular se asocia con la reducción del riesgo de muerte en pacientes hipertensos y se sugiere que este efecto protector puede ser para muerte por enfermedad cardiovascular y para muerte por cualquier causa, además se observó que en los estudios que consideraron edades de 40 a 80 años, la reducción del riesgo relativo fue del 28-67%. Por lo que se sugiere que probablemente la actividad física genere mayores beneficios en los grupos etarios de mayor edad.
The objective or aim of this review was to determine a relation between the level of realized physical activity and the reduction of the risk of death in hypertensive patients. A search was conducted for the identification of the documents from this review that included epidemiological cohort studies, relevant publications were identified in the biomedical databases PubMed and Cochrane Collaboration, the search strategy follows the recommendations of PRISMA. The results showed that an association exists between the level of physical activity and the risk of death in patients with hypertension. There was a diminution of death that ranges between 17-67 % in the hypertensive ones that do high physical activity levels. The results support the theory that regular physical activity is associated with a reduction in the rates of mortality in hypertensive patients and it is suggested that this protective effect can be of great benefit in a lower incidence of disease and cardiovascular death. In addition it is noted that the studies that consider ages of 40 to 80 years, the reduction of relative risk was 28-67%. Thus it is suggested that physical activity is likely to generate higher profits in the older age groups.
Subject(s)
Exercise , Death , HypertensionABSTRACT
OBJECTIVES: Sleep is an emerging area of concern in children with juvenile idiopathic arthritis (JIA). Research shows the presence of poor sleep quality and related adverse outcomes in pediatric pain populations, including JIA, but few studies have examined the prospective patterns of association between sleep and associated outcomes. This prospective study evaluated the direction and magnitude of associations between subjective sleep characteristics (sleep quality, difficulty initiating sleep, and sleep duration), pain intensity, and functional limitations in children with JIA. We hypothesized that pain intensity would partially mediate the relationship between sleep and functional limitations. METHODS: Children and adolescents with JIA (n=59; age range, 8 to 18 y) recruited during clinic visits, completed smartphone-based diaries for 1 month. Subjective sleep characteristics were reported each morning; pain and functioning were assessed 3 times daily. RESULTS: As hypothesized, the associations between sleep quality and functional limitations and between difficulty initiating sleep and functional limitations were partially mediated by pain intensity, at any given moment (z=-3.27, P=0.001, z=2.70, P<0.05). Mediation was not detected in a model testing the association between sleep duration, pain intensity, and functional limitations (z=-0.58, P=0.56). DISCUSSION: Results suggest that sleep is integral to understanding the momentary association between pain intensity and functioning in children with JIA.
Subject(s)
Activities of Daily Living/psychology , Arthritis, Juvenile/complications , Arthritis, Juvenile/psychology , Ecological Momentary Assessment , Pain/etiology , Sleep Wake Disorders/etiology , Adolescent , Child , Female , Humans , Male , Pain Measurement , Prospective StudiesABSTRACT
OBJECTIVE: A Center for Health Equity that included a primary care practice was built in a neighborhood affected by long-term disparities related to race and class in order to promote health equity within the population. Changes in blood pressure and HbA1c (glycated hemoglobin) over 2 years were examined to assess the impact of providing culturally appropriate and patient-centered care. METHODS: Data from June 1, 2012, to June 30, 2014 were obtained. Patients with high blood pressure or elevated HbA1c levels were treated according to evidence based guidelines. Blood pressure and HbA1c values at the first and last visit were compared using paired t tests. RESULTS: Of the 390 patients seen with a systolic pressure ≥140 mm Hg, 358 came back for at least 1 visit (92%). By the time of the last visit, 70% had values <140 mm Hg. Mean decreases for systolic and diastolic pressure between the first and last visit were statistically significant (both P < .001). Of the 88 patients seen with HbA1c values ≥7%, 68 came back for at least 1 visit (77%). By the last visit, 31% had values <7%. The change in mean HbA1c levels between the first and last visits was statistically significant (P = .001). CONCLUSION: Data from this report demonstrate statistically significant improved clinical outcomes among members of this community who sought and received care from physicians within this Center for Health Equity.
Subject(s)
Health Equity/organization & administration , Primary Health Care/methods , Blood Pressure , Cultural Competency/organization & administration , Diabetes Mellitus/therapy , Female , Glycated Hemoglobin/analysis , Health Equity/statistics & numerical data , Humans , Hypertension/therapy , Male , Middle Aged , Patient-Centered Care/methods , Primary Health Care/standards , Primary Health Care/statistics & numerical data , Treatment OutcomeABSTRACT
El nacimiento de gemelos siameses es un fenómeno extraño en las salas de parto de todo el mundo, son producto de un mismo óvulo que por alguna extraña razón no llegó a dividirse; se presenta 1/50.000 o 1/120.000 nacimientos; se estima que el 50% nace muerto y el 35% muere el primer día de vida; y el 70% son de génerofemenino. Un feto bicéfalo es un producto desarrollado con dos cabezas que se unen entre sí por medio de sus porciones temporo-parietales mediales, estando conectados vascularmente y compartiendo o no órganos entre sí; son de tipo monocigóticos y producidos por la separación anormal o incompleta de la porción axial del disco germinativo bilaminar en etapas avanzadas del desarrollo embrionario. En el presente trabajo se expone un caso de siameses bicéfalo de sexo femenino, cuyo espécimen hacía parte de las colecciones de embriología del Laboratorio de Morfología de la Universidad Tecnológica de Pereira, el cual por registro de Historia Clínica y Consentimiento Informado de la madre, quien lo entregó a la Universidad, fue sometido a descripción anatomopatológica con el fin de exponer aspectos relacionados con las posibles causas que los originaron, así como el diagnóstico prenatal de estos defectos congénitos y su diagnóstico Imagineológico postmortem.
The birth of conjoined twins is a strange phenomenon in the delivery rooms around the world, are the product of a single egg that for some reason did not divide; is presenta1 / 50,000 or 1 / 120,000 births; is estimated that 50% stillborn and 35% die on the first day of life; and 70% are female. A two-headed fetus is a product developed with two heads that are joined together through their temporoparietal medial portions being connected vascularized organs and sharing with each other or not; are monozygotic type and produced by abnormal or incomplete separation of the axial portion of the bilaminar germ disc in advanced stages of embryonic development. In this paper a case of two-headed Siamese female, whose specimen was part of the collections of Morphology Embryology Laboratory of the Technological University of Pereira, who for record medical history and informed consent of the mother who is exposed delivered to the University underwent pathological description to explain aspects of the possible causes of these accidents and the prenatal diagnosis of these congenital defects and postmortem imaging diagnosis.
O nascimento de gêmeos siameses é um fenômeno estranho nas salas de parto de todo o mundo. São produto de um mesmo óvulo, que por alguma estranha razão não chegou a dividir-se; se apresenta em 1/50.000 ou 1/120.000 nascimentos. Estima-se que 50% nascem mortos e 35% morre ao primeiro dia de vida; e 70% são do gênero feminino.Um feto bicéfalo é um produto desenvolvido com duas cabeças que se unem entre si por meio de suas porções temporão-parietais mediais, estando conectados vascular-mente e compartilham ou não órgãos entre si; são de tipo monozigóticos e produzi-dos pela separação anormal ou incompleta da porção axial do disco germinativo bi laminar em etapas avançadas do desenvolvimento embrionário. Neste trabalho se expõe o caso de siamesas bicéfalas do sexo feminino, cujo espéci-men fazem parte das coleções de embriologia do Laboratório de Morfologia da Uni-versidade Tecnológica de Pereira, que por registro de Historia Clínica e Consenti-mento Informado da mãe, que o entregou à Universidade, foi submetido a descrição anatomopatológica com o fim de expor aspectos relacionados às possíveis causas que os originaram, assim como o diagnóstico pré-natal destes defeitos congênitos e seu diagnóstico Imagiológico post-mortem.
Subject(s)
Humans , Female , Pregnancy , Blastodisc/embryology , Prenatal Diagnosis/methods , Twins, Conjoined/embryology , Ultrasonography, Prenatal/standardsABSTRACT
Primary stabbing headache (PSH) is an under-recognized primary headache disorder, which often goes undiagnosed. It is mainly characterized by its ultrashort stabbing quality and can be easily overlooked both by patients and providers as it is often not severe enough to interfere significantly with daily life. However, PSH may be severe and require therapy, and it is important for providers to recognize this headache type, both in adult and pediatric populations, as well as to be able to distinguish it from secondary headache disorders. PSH also may be more common than previously thought.